Adalimumab
In the US, Adalimumab (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Reiter's Syndrome, Rheumatoid Arthritis, Spondyloarthritis and Ulcerative Colitis.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L04AA17,L04AB04
CAS registry number (Chemical Abstracts Service)
0331731-18-1
Chemical Formula
C6428-H9912-N1694-O1987-S46
Molecular Weight
144190
Therapeutic Categories
Immunosuppressant
Disease-modifying antirheumatic drug, DMARD
Anti-inflammatory agent
Monoclonal antibody
Tumor necrosis factor alpha (TNF-α) inhibitor
Chemical Name
Immunoglobulin G 1 (human monoclonal D2E7 heavy chain anti-human tumor necrosis factor), disulfide with human monoclonal D2E7κ-chain, dimer (WHO )
Foreign Names
- Adalimumabum (Latin)
- Adalimumab (German)
- Adalimumab (French)
- Adalimumab (Spanish)
Generic Names
- Adalimumab (OS: BAN, USAN)
- Adalimumab (Genetical Recombination) (OS: JAN)
- D 2E7 (IS)
- LU 200134 (IS)
Brand Names
- Humira
Abbott, Argentina; Abbott, Australia; Abbott, Belgium; Abbott, Bahrain; Abbott, Canada; Abbott, Switzerland; Abbott, Chile; Abbott, China; Abbott, Colombia; Abbott, Czech Republic; Abbott, Germany; Abbott, Denmark; Abbott, Ecuador; Abbott, Spain; Abbott, Finland; Abbott, France; Abbott, Greece; Abbott, Guatemala; Abbott, Hong Kong; Abbott, Honduras; Abbott, Croatia (Hrvatska); Abbott, Hungary; Abbott, Ireland; Abbott, Israel; Abbott, Italy; Abbott, South Korea; Abbott, Luxembourg; Abbott, Latvia; Abbott, Mexico; Abbott, Malaysia; Abbott, Netherlands; Abbott, Norway; Abbott, New Zealand; Abbott, Oman; Abbott, Panama; Abbott, Peru; Abbott, Poland; Abbott, Portugal; Abbott, Romania; Abbott, Serbia; Abbott, Russian Federation; Abbott, Sweden; Abbott, Singapore; Abbott, Slovenia; Abbott, Slovakia; Abbott, El Salvador; Abbott, Tunisia; Abbott, Turkey; Abbott, Taiwan; Abbott, United States; Abbott, South Africa; Abbott Japan, Japan; Abbott Laboratories, Austria; Abbott Laboratories S.A., Lithuania; AbbVie, United Kingdom - Trudexa
Abbott, Latvia
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
